This product is for research use only, not for human use. We do not sell to patients.
Size | Price | Stock |
---|---|---|
5g | $100 | 3-6 Days |
10g | $150 | 3-6 Days |
25g | $250 | 3-6 Days |
50g | $400 | 3-6 Days |
Cat #: V27879 CAS #: 4105-38-8 Purity ≥ 99%
Description: Uridine triacetate (PN-401; RG 2133; Vistogard; Vistonuridine; Xuriden; Triacetyluridine; TAU), a prodrug of uridine, is an approved medication used for treatment of hereditary orotic aciduria or to treat patients following an overdose of chemotherapy drugs 5-fluorouracil or capecitabine. The acetyl groups of Vistonuridine increase the lipophilicity of uridine, thus enhancing its transport from the gastrointestinal tract to the blood stream and its reabsorption from the renal tubules, while rendering Vistonuridine resistant to catabolism by UrdPase. Uridine triacetate was granted breakthrough therapy designation by FDA in 2015. Uridine triacetate is a prodrug of uridine.
Publications Citing InvivoChem Products
Product Promise
- Physicochemical and Storage Information
- Protocol
- Related Biological Data
- Stock Solution Preparation
- Quality Control Documentation
Molecular Weight (MW) | 370.31 |
---|---|
Molecular Formula | C15H18N2O9 |
CAS No. | 4105-38-8 |
Synonyms | PN401, RG-2133, PN 401, RG2133, PN-401, RG 2133, Tri-O-acetyluridine, Triacetyluridine, Uridine triacetate, Vistogard, Vistonuridine |
Solvent volume to be added | Mass (the weight of a compound) | |||
---|---|---|---|---|
Mother liquor concentration | 1mg | 5mg | 10mg | 20mg |
1mM | 2.7004 mL | 13.5022 mL | 27.0044 mL | 54.0088 mL |
5mM | 0.5401 mL | 2.7004 mL | 5.4009 mL | 10.8018 mL |
10mM | 0.2700 mL | 1.3502 mL | 2.7004 mL | 5.4009 mL |
20mM | 0.1350 mL | 0.6751 mL | 1.3502 mL | 2.7004 mL |
This equation is commonly abbreviated as: C1 V1 = C2 V2
- (1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
- (2) Be sure to add the solvent(s) in order.